The story of copyright's flagship drug presents a nuanced case for stakeholders in the medicinal sector. While initially a phenomenal success, producing billions, the patent lapse and the subsequent entry of off-brand https://escort209276.idblogz.com/42110508/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-play